Total Payments
$38,759
2024 Payments
$1,023
Companies
32
Transactions
344
Medicare Patients
11,018
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$22,334 (57.6%)
Food & Beverage$12,597 (32.5%)
Travel$3,757 (9.7%)
Education$71.45 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,334 | 14 | 57.6% |
| Food and Beverage | $12,597 | 310 | 32.5% |
| Travel and Lodging | $3,757 | 13 | 9.7% |
| Education | $71.45 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $15,880 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $9,442 | 59 | $0 (2024) |
| Medtronic Vascular, Inc. | $3,811 | 35 | $0 (2020) |
| Boston Scientific Corporation | $2,828 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,579 | 49 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,073 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $627.02 | 9 | $0 (2022) |
| PFIZER INC. | $553.55 | 23 | $0 (2024) |
| Abbott Laboratories | $484.74 | 9 | $0 (2024) |
| ABIOMED | $425.13 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,023 | 40 | Boston Scientific Corporation ($218.61) |
| 2023 | $450.75 | 12 | Medtronic, Inc. ($123.98) |
| 2022 | $2,758 | 39 | Boston Scientific Corporation ($1,578) |
| 2021 | $5,882 | 32 | Amgen Inc. ($2,992) |
| 2020 | $10,874 | 32 | AstraZeneca Pharmaceuticals LP ($5,898) |
| 2019 | $6,156 | 60 | Amgen Inc. ($2,411) |
| 2018 | $9,234 | 63 | Amgen Inc. ($7,066) |
| 2017 | $2,382 | 66 | Novartis Pharmaceuticals Corporation ($361.72) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.42 | General |
| 11/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardiology | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.51 | General |
| 10/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.64 | General |
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardio-renal | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.54 | General |
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,297 | 5,903 | $1.3M | $372,621 |
| 2022 | 23 | 2,581 | 5,401 | $1.5M | $430,099 |
| 2021 | 22 | 2,640 | 5,264 | $1.6M | $469,545 |
| 2020 | 31 | 2,500 | 5,372 | $1.4M | $398,443 |
Total Patients
11,018
Total Services
21,940
Medicare Billing
$1.7M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 373 | 923 | $311,480 | $92,246 | 29.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 143 | 466 | $123,189 | $47,761 | 38.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 259 | 268 | $145,792 | $42,749 | 29.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 67 | 196 | $141,708 | $35,624 | 25.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 61 | 61 | $78,934 | $23,657 | 30.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 108 | 110 | $59,400 | $17,059 | 28.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 105 | $53,130 | $15,651 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 77 | 77 | $44,683 | $13,156 | 29.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 62 | 124 | $61,504 | $12,155 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 412 | 1,056 | $40,528 | $12,068 | 29.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 62 | 248 | $36,952 | $9,985 | 27.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 970 | 1,379 | $29,111 | $9,632 | 33.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 31 | 32 | $21,952 | $6,776 | 30.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 116 | 120 | $64,754 | $6,526 | 10.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 70 | 71 | $25,489 | $6,419 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 31 | $14,737 | $4,565 | 31.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 84 | 87 | $17,422 | $4,480 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 49 | $11,574 | $3,829 | 33.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 59 | 60 | $12,840 | $3,279 | 25.5% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 104 | 344 | $6,192 | $2,000 | 32.3% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 16 | 16 | $4,576 | $1,918 | 41.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 18 | 41 | $2,829 | $748.51 | 26.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 13 | $338.00 | $134.55 | 39.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 13 | $143.00 | $103.60 | 72.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 12 | 13 | $247.00 | $98.93 | 40.1% |
About Dr. Nirav Shah, MD
Dr. Nirav Shah, MD is a Cardiovascular Disease healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023083607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nirav Shah, MD has received a total of $38,759 in payments from pharmaceutical and medical device companies, with $1,023 received in 2024. These payments were reported across 344 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,334).
As a Medicare-enrolled provider, Shah has provided services to 11,018 Medicare beneficiaries, totaling 21,940 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Newburgh, NY
- Active Since 02/17/2006
- Last Updated 08/28/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1023083607
Products in Payments
- Repatha (Biological) $15,679
- LOKELMA (Drug) $8,139
- Resolute (Device) $3,263
- XARELTO (Drug) $1,776
- General - Therapies (Device) $1,396
- BRILINTA (Drug) $1,041
- ELIQUIS (Drug) $973.24
- ENTRESTO (Drug) $885.75
- Impella (Device) $425.13
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $370.05
- WOLVERINE CORONARY CUTTING BALLOON (Device) $264.20
- FARXIGA (Drug) $262.28
- WATCHMAN (Device) $235.72
- Corlanor (Drug) $191.01
- LEQVIO (Drug) $187.22
- CoreValve Evolut (Device) $179.80
- RESONATE (Device) $159.91
- ZONTIVITY (Drug) $157.14
- PRALUENT (Drug) $148.09
- Vascepa (Drug) $146.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Newburgh
Mehul Patel, Md Facc, MD FACC
Cardiovascular Disease — Payments: $128,348
Cardiovascular Disease $128,348
Dr. James Neahring, M.d, M.D
Cardiovascular Disease — Payments: $103,084
Cardiovascular Disease $103,084
Dr. Chandrashekar Kumbar, Md, MD
Cardiovascular Disease — Payments: $50,385
Cardiovascular Disease $50,385
Dr. Jonathan Balagna, M.d, M.D
Cardiovascular Disease — Payments: $15,332
Cardiovascular Disease $15,332
Nathan Reed, Md, MD
Cardiovascular Disease — Payments: $13,640
Cardiovascular Disease $13,640
Shmuel Shapira, Md, MD
Cardiovascular Disease — Payments: $10,498
Cardiovascular Disease $10,498